Invention Grant
US07645776B2 Heteroaryl substituted piperidine derivatives which are L-CPT1 inhibitors
失效
作为L-CPT1抑制剂的杂芳基取代的哌啶衍生物
- Patent Title: Heteroaryl substituted piperidine derivatives which are L-CPT1 inhibitors
- Patent Title (中): 作为L-CPT1抑制剂的杂芳基取代的哌啶衍生物
-
Application No.: US11605904Application Date: 2006-11-29
-
Publication No.: US07645776B2Publication Date: 2010-01-12
- Inventor: Jean Ackermann , Konrad Bleicher , Simona M. Ceccarelli Grenz , Odile Chomienne , Patrizio Mattei , Tanja Schulz-Gasch
- Applicant: Jean Ackermann , Konrad Bleicher , Simona M. Ceccarelli Grenz , Odile Chomienne , Patrizio Mattei , Tanja Schulz-Gasch
- Applicant Address: US NJ Nutley
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Nutley
- Agent George W. Johnston; Dennis P. Tramaloni; Samuel H. Megerditchian
- Priority: EP05111560 20051201
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07D413/12 ; A61K31/541 ; A61K31/5377

Abstract:
The invention is concerned with novel substituted piperidine derivatives of formula (I) wherein R1, R2, R3, R4, R5, R6, R7 and X are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPT1 and can be used as medicaments.
Public/Granted literature
- US20070129544A1 Novel heteroaryl substituted piperidine derivatives which are L-CPT1 inhibitors Public/Granted day:2007-06-07
Information query